Fig. 1From: Efficacy and safety of osimertinib for leptomeningeal metastases from EGFR-mutant non-small cell lung cancer: a pooled analysisPreferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) Flow DiagramBack to article page